Warren Lucinda bought CUE
April 9, 2026 · Form 4 insider transaction
Warren Lucinda bought 250,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
250,000
Price
$0.00
Total value
N/A
InsiderWarren Lucinda
RoleOfficer
CompanyCue Biopharma, Inc. (CUE)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 9, 2026
Filing dateApril 10, 2026
Shares owned after250,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option becomes exercisable over four years, with 25% vesting on the one year anniversary of the grant date and the remainder vesting in equal, semi-annual installments thereafter.